Eastern Bank cut its stake in Cabot Corporation (NYSE:CBT – Free Report) by 3.4% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 238,845 shares of the specialty chemicals company’s stock after selling 8,298 shares during the quarter. Eastern Bank owned about 0.45% of Cabot worth $18,164,000 as of its most recent SEC filing.
Several other institutional investors have also modified their holdings of the stock. Franklin Resources Inc. grew its holdings in shares of Cabot by 1.7% in the second quarter. Franklin Resources Inc. now owns 10,551 shares of the specialty chemicals company’s stock valued at $791,000 after purchasing an additional 181 shares during the period. Parkside Financial Bank & Trust raised its stake in Cabot by 95.5% during the second quarter. Parkside Financial Bank & Trust now owns 387 shares of the specialty chemicals company’s stock worth $29,000 after purchasing an additional 189 shares during the period. Ferguson Wellman Capital Management Inc. boosted its holdings in Cabot by 4.2% in the 2nd quarter. Ferguson Wellman Capital Management Inc. now owns 5,000 shares of the specialty chemicals company’s stock valued at $375,000 after purchasing an additional 200 shares during the last quarter. GAMMA Investing LLC grew its stake in shares of Cabot by 12.3% in the 2nd quarter. GAMMA Investing LLC now owns 1,909 shares of the specialty chemicals company’s stock valued at $143,000 after buying an additional 209 shares during the period. Finally, UMB Bank n.a. grew its stake in shares of Cabot by 52.4% in the 2nd quarter. UMB Bank n.a. now owns 730 shares of the specialty chemicals company’s stock valued at $55,000 after buying an additional 251 shares during the period. Hedge funds and other institutional investors own 93.18% of the company’s stock.
Wall Street Analysts Forecast Growth
CBT has been the topic of several analyst reports. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Cabot in a research report on Monday, December 29th. JPMorgan Chase & Co. reduced their target price on Cabot from $75.00 to $54.00 and set an “underweight” rating on the stock in a research report on Friday, November 28th. UBS Group upped their price target on Cabot from $65.00 to $74.00 and gave the company a “neutral” rating in a research note on Monday. Zacks Research downgraded Cabot from a “hold” rating to a “strong sell” rating in a research report on Friday, November 7th. Finally, Mizuho boosted their price objective on shares of Cabot from $72.00 to $80.00 and gave the company an “outperform” rating in a report on Thursday, December 18th. Two equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, Cabot has an average rating of “Hold” and a consensus target price of $72.25.
Cabot Trading Down 2.0%
Shares of NYSE CBT opened at $71.59 on Wednesday. The company has a current ratio of 1.61, a quick ratio of 1.08 and a debt-to-equity ratio of 0.50. The stock has a market capitalization of $3.79 billion, a PE ratio of 11.91, a PEG ratio of 3.83 and a beta of 0.89. Cabot Corporation has a twelve month low of $58.33 and a twelve month high of $92.89. The stock has a fifty day simple moving average of $65.22 and a 200-day simple moving average of $72.18.
Cabot (NYSE:CBT – Get Free Report) last announced its earnings results on Monday, November 3rd. The specialty chemicals company reported $1.70 EPS for the quarter, missing analysts’ consensus estimates of $1.72 by ($0.02). The firm had revenue of $899.00 million for the quarter, compared to analysts’ expectations of $967.02 million. Cabot had a net margin of 8.91% and a return on equity of 24.55%. The business’s revenue was down 10.2% compared to the same quarter last year. During the same quarter last year, the business earned $1.80 earnings per share. Cabot has set its FY 2026 guidance at 6.000-7.00 EPS. On average, equities analysts forecast that Cabot Corporation will post 7.57 earnings per share for the current year.
Cabot Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, December 12th. Shareholders of record on Friday, November 28th were given a $0.45 dividend. This represents a $1.80 annualized dividend and a yield of 2.5%. The ex-dividend date of this dividend was Friday, November 28th. Cabot’s dividend payout ratio (DPR) is currently 29.95%.
About Cabot
Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.
The company operates two primary segments: Reinforcement Materials and Performance Materials.
Featured Stories
- Five stocks we like better than Cabot
- “Ominous day” coming to stocks…
- Punch these codes into your ordinary brokerage account
- The Crash Has Already Started (Most Just Don’t See It Yet)
- Trump Planning to Use Public Law 63-43: Prepare Now
- A month before the crash
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.
